Merck KGaA (OTCMKTS:MKGAF) Shares Up 6.9% – Time to Buy?

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s stock price shot up 6.9% on Wednesday . The stock traded as high as $138.51 and last traded at $138.51. 34 shares changed hands during trading, a decline of 96% from the average session volume of 911 shares. The stock had previously closed at $129.51.

Merck KGaA Trading Up 0.8%

The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market capitalization of $16.88 billion, a price-to-earnings ratio of 19.94 and a beta of 0.96. The business’s 50-day simple moving average is $132.58 and its 200-day simple moving average is $132.20.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

See Also

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.